Skip to main content
Erschienen in: Clinical & Experimental Metastasis 4/2013

01.04.2013 | Research Paper

Sex-dependent liver colonization of human melanoma in SCID mice—role of host defense mechanisms

verfasst von: Judit Dobos, Anita Mohos, József Tóvári, Erzsébet Rásó, Tamás Lőrincz, Gergely Zádori, József Tímár, Andrea Ladányi

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

The possibility that endocrine factors may influence the clinical course of malignant melanoma is suggested by the superior survival data of women. In preclinical models we observed a higher rate of colony formation by human melanoma cells in male compared to female SCID mice, but only in the case of the liver and not in other organs. The gender difference could be seen at an early phase of colony formation. On the other hand, in our human melanoma cell lines we failed to detect steroid receptor protein expression, and treatment with sex hormones did not considerably influence their in vitro behavior. Investigating the possible contribution of host cells to the observed gender difference, we performed in vivo blocking experiments applying pretreatment of the animals with Kupffer cell inhibitor gadolinium chloride and the NK cell inhibitor anti-asialo GM1 antibody. While Kupffer cell blockade enhanced melanoma liver colonization equally in the two sexes, a more prominent increase was observed in female than in male mice in the case of NK cell inhibition. Further supporting the importance of NK cells in the lower liver colonization efficiency of melanoma cells in females, gender difference in colony formation was lost in NSG mice lacking NK activity. Although in humans no organ selectivity of gender difference in melanoma progression has been observed according to data in the literature, our results possibly indicate a contribution of natural host defense mechanisms to gender difference in survival of patients with melanoma or other tumor types as well.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
Zurück zum Zitat Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G, De Angelis R, The EUROCARE working group (2009) The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 45:1017–1027PubMedCrossRef Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, Zambon P, Gatta G, De Angelis R, The EUROCARE working group (2009) The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 45:1017–1027PubMedCrossRef
3.
Zurück zum Zitat Wolf M, Holle R, Hans K, Drings P, Havemann K (1991) Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 63:986–992PubMedCrossRef Wolf M, Holle R, Hans K, Drings P, Havemann K (1991) Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 63:986–992PubMedCrossRef
4.
Zurück zum Zitat Franco EL, Dib LL, Pinto DS, Lombardo V, Contesini H (1993) Race and gender influences on the survival of patients with mouth cancer. J Clin Epidemiol 46:37–46PubMedCrossRef Franco EL, Dib LL, Pinto DS, Lombardo V, Contesini H (1993) Race and gender influences on the survival of patients with mouth cancer. J Clin Epidemiol 46:37–46PubMedCrossRef
5.
Zurück zum Zitat Molife R, Lorigan P, MacNeil S (2001) Gender and survival in malignant tumours. Cancer Treat Rev 27:201–209PubMedCrossRef Molife R, Lorigan P, MacNeil S (2001) Gender and survival in malignant tumours. Cancer Treat Rev 27:201–209PubMedCrossRef
6.
Zurück zum Zitat McArdle CS, McMillan DC, Hole DJ (2003) Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 90:711–715PubMedCrossRef McArdle CS, McMillan DC, Hole DJ (2003) Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 90:711–715PubMedCrossRef
7.
Zurück zum Zitat Visbal AL, Williams BA, Nichols FC 3rd, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P (2004) Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 78:209–215PubMedCrossRef Visbal AL, Williams BA, Nichols FC 3rd, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P (2004) Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 78:209–215PubMedCrossRef
8.
9.
Zurück zum Zitat Kemeny MM, Busch E, Stewart AK, Menck HR (1998) Superior survival of young women with malignant melanoma. Am J Surg 175:437–445PubMedCrossRef Kemeny MM, Busch E, Stewart AK, Menck HR (1998) Superior survival of young women with malignant melanoma. Am J Surg 175:437–445PubMedCrossRef
10.
Zurück zum Zitat Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RCG, Stromberg AJ, Hagendoorn L, McMasters KM, The Sunbelt melanoma trial (2006) Gender-related differences in outcome for melanoma patients. Ann Surg 243:693–700PubMedCrossRef Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RCG, Stromberg AJ, Hagendoorn L, McMasters KM, The Sunbelt melanoma trial (2006) Gender-related differences in outcome for melanoma patients. Ann Surg 243:693–700PubMedCrossRef
11.
Zurück zum Zitat de Vries E, Nijsten TEC, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, Coebergh JWW (2008) Superior survival of females among 10 538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 19:583–589PubMedCrossRef de Vries E, Nijsten TEC, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, Coebergh JWW (2008) Superior survival of females among 10 538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 19:583–589PubMedCrossRef
12.
Zurück zum Zitat Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C (2008) Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112:1795–1804PubMedCrossRef Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C (2008) Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112:1795–1804PubMedCrossRef
13.
Zurück zum Zitat Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AMM, Hölzel D, Coebergh JWW, Engel J (2011) Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 131:719–726PubMedCrossRef Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AMM, Hölzel D, Coebergh JWW, Engel J (2011) Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 131:719–726PubMedCrossRef
14.
Zurück zum Zitat Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, Coebergh JWW, Eggermont AMM, de Vries E (2012) Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European organisation for research and treatment of cancer phase III trials. J Clin Oncol. doi:10.1200/JCO.2011.38.0584 PubMed Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, Coebergh JWW, Eggermont AMM, de Vries E (2012) Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European organisation for research and treatment of cancer phase III trials. J Clin Oncol. doi:10.​1200/​JCO.​2011.​38.​0584 PubMed
15.
Zurück zum Zitat Stidham KR, Johnson JL, Seigler HF (1994) Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Ann Surg 129:316–324 Stidham KR, Johnson JL, Seigler HF (1994) Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Ann Surg 129:316–324
16.
Zurück zum Zitat Neifeld JP, Lippman ME (1980) Steroid hormone receptors and melanoma. J Invest Dermatol 74:379–381PubMedCrossRef Neifeld JP, Lippman ME (1980) Steroid hormone receptors and melanoma. J Invest Dermatol 74:379–381PubMedCrossRef
17.
Zurück zum Zitat Kokoschka E-M, Spona J, Knobler R (1982) Sex steroid hormone receptor analysis in malignant melanoma. Br J Dermat 107(Suppl 23):54–59CrossRef Kokoschka E-M, Spona J, Knobler R (1982) Sex steroid hormone receptor analysis in malignant melanoma. Br J Dermat 107(Suppl 23):54–59CrossRef
18.
Zurück zum Zitat Duncan LM, Travers RL, Koerner FC, Mihm MC Jr, Sober AJ (1994) Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: absence of immunohistochemically detectable hormone receptors. Hum Pathol 25:36–41PubMedCrossRef Duncan LM, Travers RL, Koerner FC, Mihm MC Jr, Sober AJ (1994) Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: absence of immunohistochemically detectable hormone receptors. Hum Pathol 25:36–41PubMedCrossRef
19.
Zurück zum Zitat Morvillo V, Luthy IA, Bravo AI, Capurro MI, Portela P, Calandra RS, Mordoh J (2002) Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases. Melanoma Res 12:529–538PubMedCrossRef Morvillo V, Luthy IA, Bravo AI, Capurro MI, Portela P, Calandra RS, Mordoh J (2002) Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases. Melanoma Res 12:529–538PubMedCrossRef
20.
Zurück zum Zitat Feucht KA, Walker MJ, Das Gupta TK, Beattie CW (1988) Effect of 17β-estradiol on the growth of estrogen receptor–positive human melanoma in vitro and in athymic mice. Cancer Res 48:7093–7101PubMed Feucht KA, Walker MJ, Das Gupta TK, Beattie CW (1988) Effect of 17β-estradiol on the growth of estrogen receptor–positive human melanoma in vitro and in athymic mice. Cancer Res 48:7093–7101PubMed
21.
Zurück zum Zitat Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, Miller JG, Mac Neil S (1999) Investigation of female survival benefit in metastatic melanoma. Br J Cancer 80:2025–2033PubMedCrossRef Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, Miller JG, Mac Neil S (1999) Investigation of female survival benefit in metastatic melanoma. Br J Cancer 80:2025–2033PubMedCrossRef
22.
Zurück zum Zitat Proctor JW, Auclair BG, Stokowski L (1976) Endrocrine factors and the growth and spread of B16 melanoma. J Natl Cancer Inst 57:1197–1198PubMed Proctor JW, Auclair BG, Stokowski L (1976) Endrocrine factors and the growth and spread of B16 melanoma. J Natl Cancer Inst 57:1197–1198PubMed
23.
Zurück zum Zitat Lopez RE, Bhakoo H, Paolini NS, Rosen F, Holyoke ED, Goldrosen MH (1978) Effect of estrogen on the growth of B-16 melanoma. Surg Forum 29:153–154PubMed Lopez RE, Bhakoo H, Paolini NS, Rosen F, Holyoke ED, Goldrosen MH (1978) Effect of estrogen on the growth of B-16 melanoma. Surg Forum 29:153–154PubMed
24.
Zurück zum Zitat Simon SR, Ershler WB (1985) Hormonal influences on growth of B16 murine melanoma. J Natl Cancer Inst 74:1085–1088PubMed Simon SR, Ershler WB (1985) Hormonal influences on growth of B16 murine melanoma. J Natl Cancer Inst 74:1085–1088PubMed
25.
Zurück zum Zitat Hirayama R, Hirokawa K, Makinodan T (1985) Change in the metastatic mode of B16 malignant melanoma in C57BL/6 mice with ageing and sex. IARC Sci Publ 58:85–96PubMed Hirayama R, Hirokawa K, Makinodan T (1985) Change in the metastatic mode of B16 malignant melanoma in C57BL/6 mice with ageing and sex. IARC Sci Publ 58:85–96PubMed
26.
Zurück zum Zitat Walker MJ, Chaudhuri PK, Das Gupta TK, Beattie CW (1980) Influence of host sex on the growth of human melanoma. Proc Soc Exp Biol Med 165:96–99PubMed Walker MJ, Chaudhuri PK, Das Gupta TK, Beattie CW (1980) Influence of host sex on the growth of human melanoma. Proc Soc Exp Biol Med 165:96–99PubMed
27.
Zurück zum Zitat Ladányi A, Tímár J, Bocsi J, Tóvári J, Lapis K (1995) Sex-dependent liver metastasis of human melanoma lines in SCID mice. Melanoma Res 5:83–86PubMedCrossRef Ladányi A, Tímár J, Bocsi J, Tóvári J, Lapis K (1995) Sex-dependent liver metastasis of human melanoma lines in SCID mice. Melanoma Res 5:83–86PubMedCrossRef
28.
Zurück zum Zitat Ladányi A, Tímár J, Paku S, Molnár G, Lapis K (1990) Selection and characterization of human melanoma lines with different liver-colonizing capacity. Int J Cancer 46:456–461PubMedCrossRef Ladányi A, Tímár J, Paku S, Molnár G, Lapis K (1990) Selection and characterization of human melanoma lines with different liver-colonizing capacity. Int J Cancer 46:456–461PubMedCrossRef
29.
Zurück zum Zitat Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555–1577PubMedCrossRef Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555–1577PubMedCrossRef
30.
Zurück zum Zitat Paku S, Rot A, Ladányi A, Lapis K (1989) Demonstration of the organ preference of liver selected ‘high metastatic’ Lewis lung tumor cell line. Clin Exp Metastasis 7:599–607PubMedCrossRef Paku S, Rot A, Ladányi A, Lapis K (1989) Demonstration of the organ preference of liver selected ‘high metastatic’ Lewis lung tumor cell line. Clin Exp Metastasis 7:599–607PubMedCrossRef
31.
Zurück zum Zitat Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T (2002) NOD/SCIDγ c null mouse: and excellent recipient mouse model for engraftment of human cells. Blood 100:3175–3182PubMedCrossRef Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T (2002) NOD/SCIDγ c null mouse: and excellent recipient mouse model for engraftment of human cells. Blood 100:3175–3182PubMedCrossRef
32.
Zurück zum Zitat Paku S, Döme B, Tóth R, Tímár J (2000) Organ-specificity of the extravasation process: and ultrastructural study. Clin Exp Metastasis 18:481–492PubMedCrossRef Paku S, Döme B, Tóth R, Tímár J (2000) Organ-specificity of the extravasation process: and ultrastructural study. Clin Exp Metastasis 18:481–492PubMedCrossRef
33.
Zurück zum Zitat Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A (2004) In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int J Cancer 112:771–776PubMedCrossRef Dobos J, Tímár J, Bocsi J, Burián Z, Nagy K, Barna G, Peták I, Ladányi A (2004) In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. Int J Cancer 112:771–776PubMedCrossRef
34.
Zurück zum Zitat Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423PubMedCrossRef Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423PubMedCrossRef
35.
Zurück zum Zitat Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N (1997) Cutaneous malignant melanoma in Southern Sweden 1965, 1975, and 1985 Prognostic factors and histologic correlations. Cancer 79:275–283PubMedCrossRef Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N (1997) Cutaneous malignant melanoma in Southern Sweden 1965, 1975, and 1985 Prognostic factors and histologic correlations. Cancer 79:275–283PubMedCrossRef
36.
Zurück zum Zitat Larsen TE, Grude TH (1978) A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis. Acta Pathol Microbiol Scand (A) 86A:523–530 Larsen TE, Grude TH (1978) A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis. Acta Pathol Microbiol Scand (A) 86A:523–530
37.
Zurück zum Zitat Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS (2007) Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 25:869–875PubMedCrossRef Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS (2007) Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 25:869–875PubMedCrossRef
38.
Zurück zum Zitat Kiss J, Tímár J, Somlai B, Gilde K, Fejős Z, Gaudi I, Ladányi A (2007) Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathol Oncol Res 13:21–31PubMedCrossRef Kiss J, Tímár J, Somlai B, Gilde K, Fejős Z, Gaudi I, Ladányi A (2007) Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathol Oncol Res 13:21–31PubMedCrossRef
39.
Zurück zum Zitat Ladányi A, Somlai B, Gilde K, Fejös Z, Gaudi I, Tímár J (2004) T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10:521–530PubMedCrossRef Ladányi A, Somlai B, Gilde K, Fejös Z, Gaudi I, Tímár J (2004) T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10:521–530PubMedCrossRef
40.
Zurück zum Zitat Ladányi A, Kiss J, Somlai B, Gilde K, Fejős Z, Mohos A, Gaudi I, Tímár J (2007) Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 56:1459–1469PubMedCrossRef Ladányi A, Kiss J, Somlai B, Gilde K, Fejős Z, Mohos A, Gaudi I, Tímár J (2007) Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 56:1459–1469PubMedCrossRef
41.
Zurück zum Zitat Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejős Z, Gaudi I, Dobos J, Tímár J (2011) Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol Immunother 60:1729–1738PubMedCrossRef Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejős Z, Gaudi I, Dobos J, Tímár J (2011) Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol Immunother 60:1729–1738PubMedCrossRef
42.
Zurück zum Zitat Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE (1985) Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134:4267–4275PubMed Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE (1985) Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134:4267–4275PubMed
43.
Zurück zum Zitat Roh MS, Kahky MP, Oyedeji C, Klostergaard J, Wang L, Curley SA, Lotzová E (1992) Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases. Clin Exp Metastasis 10:317–327PubMedCrossRef Roh MS, Kahky MP, Oyedeji C, Klostergaard J, Wang L, Curley SA, Lotzová E (1992) Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases. Clin Exp Metastasis 10:317–327PubMedCrossRef
44.
Zurück zum Zitat Timmers M, Vekemans K, Vermijlen D, De Zanger R, Wisse E, Braet F (2004) Confocal laser scanning microscopic study of the killing of metastatic colon carcinoma cells by Kupffer cells in the early onset of hepatic metastasis. Comp Hepatol 3(Suppl 1):S50PubMedCrossRef Timmers M, Vekemans K, Vermijlen D, De Zanger R, Wisse E, Braet F (2004) Confocal laser scanning microscopic study of the killing of metastatic colon carcinoma cells by Kupffer cells in the early onset of hepatic metastasis. Comp Hepatol 3(Suppl 1):S50PubMedCrossRef
45.
Zurück zum Zitat Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121–124PubMedCrossRef Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121–124PubMedCrossRef
46.
Zurück zum Zitat Wright PFA, Stacey NH (1991) A species/strain comparison of hepatic natural lymphocytotoxic activities in rats and mice. Carcinogenesis 12:1365–1370PubMedCrossRef Wright PFA, Stacey NH (1991) A species/strain comparison of hepatic natural lymphocytotoxic activities in rats and mice. Carcinogenesis 12:1365–1370PubMedCrossRef
47.
Zurück zum Zitat Wichmann MW, Müller C, Meyer G, Adam M, Angele MK, Eisenmenger SJ, Schildberg F-W (2003) Different immune responses to abdominal surgery in men and women. Langenbecks Arch Surg 387:397–401PubMed Wichmann MW, Müller C, Meyer G, Adam M, Angele MK, Eisenmenger SJ, Schildberg F-W (2003) Different immune responses to abdominal surgery in men and women. Langenbecks Arch Surg 387:397–401PubMed
48.
Zurück zum Zitat Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumor formation by single human melanoma cells. Nature 456:593–598PubMedCrossRef Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumor formation by single human melanoma cells. Nature 456:593–598PubMedCrossRef
49.
Zurück zum Zitat Carreno BM, Garbow JR, Kolar GR, Jackson EN, Engelbach JA, Becker-Hapak M, Carayannopoulos LN, Piwnica-Worms D, Linette GP (2009) Immune-deficient mouse strains display marked variability in growth of human melanoma lung metastases. Clin Cancer Res 15:3277–3286PubMedCrossRef Carreno BM, Garbow JR, Kolar GR, Jackson EN, Engelbach JA, Becker-Hapak M, Carayannopoulos LN, Piwnica-Worms D, Linette GP (2009) Immune-deficient mouse strains display marked variability in growth of human melanoma lung metastases. Clin Cancer Res 15:3277–3286PubMedCrossRef
50.
Zurück zum Zitat Joosse A, de Vries E, van Eijck CH, Eggermont AMM, Nijsten T, Coebergh JWW (2010) Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res 23:352–364PubMedCrossRef Joosse A, de Vries E, van Eijck CH, Eggermont AMM, Nijsten T, Coebergh JWW (2010) Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res 23:352–364PubMedCrossRef
Metadaten
Titel
Sex-dependent liver colonization of human melanoma in SCID mice—role of host defense mechanisms
verfasst von
Judit Dobos
Anita Mohos
József Tóvári
Erzsébet Rásó
Tamás Lőrincz
Gergely Zádori
József Tímár
Andrea Ladányi
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 4/2013
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-012-9554-5

Weitere Artikel der Ausgabe 4/2013

Clinical & Experimental Metastasis 4/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.